Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Ferrol – page 4

60 clinical trials in Ferrol, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Ferrol at a glance
60
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

60 trials in Ferrol

Open in trial search

A Study of Inhaled Fexlamose for Adults with Moderate to Severe Chronic Obstructive Pulmonary Disease

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:6-THIO-ALFA-D-GLUCOPYRANOSYL 6-THIO-ALFA-D-GLUCOPYRANOSIDE
  • Sponsor:Aer Therapeutics Inc.

Study comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:RO7795081
  • Sponsor:F. Hoffmann-La Roche AG

Obesity+1

Not recruiting

Study on the Effects of RO7204239 and Tirzepatide for Weight Loss in Patients with Obesity or Overweight with a Weight-Related Health Issue

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tirzepatide
  • Sponsor:F. Hoffmann-La Roche AG

Diabetes mellitus

Not recruiting

Study on Switching to Insulin Glargine 300 U/ml from Insulin Glargine 100 U/ml for Patients with Type 2 Diabetes and Kidney Problems

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Sponsor:Sanofi Aventis S.A.

Crohn's disease

Not recruiting

Study on Upadacitinib for Children with Moderate to Severe Crohn's Disease

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Ciprofloxacin
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Diabetic retinopathy+1

Not recruiting

Study on the Effectiveness and Safety of BAY 3283142 in Reducing Urine Albumin for Patients with Chronic Kidney Disease

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:BAY 3283142
  • Sponsor:Bayer AG

Crohn's disease

Not recruiting

Study on the Effectiveness and Safety of Guselkumab for Patients with Fistulizing Perianal Crohn's Disease

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Study on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:JTT-861 monohydrochloride dihydrate
  • Sponsor:Akros Pharma Inc.

Hypertension

Not recruiting

Study on Baxdrostat for Reducing Blood Pressure in Patients with Uncontrolled or Resistant Hypertension

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
  • Sponsor:Janssen Cilag International

Study on the Effectiveness and Safety of Finerenone for Adults with Non-Diabetic Chronic Kidney Disease

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Diabetic nephropathy

Not recruiting

Study on the Effectiveness and Safety of Finerenone and Empagliflozin in Adults with Chronic Kidney Disease and Type 2 Diabetes

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Empagliflozin
  • Sponsor:Bayer AG

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Ferrol

What the registry says about research in the country

01 Metabolic Disorders

Clinical research focusing on innovative treatments for Type 2 Diabetes and obesity management. Studies evaluate new insulin formulations and novel therapeutic approaches for weight management.

  • Diabetes management strategies
  • Weight loss interventions
  • Metabolic health optimization

Multiple trials exploring dual-action medications targeting both obesity and associated conditions.

02 Gastrointestinal Diseases

Comprehensive research into inflammatory bowel conditions, including Ulcerative Colitis and Crohn's Disease. Studies focus on novel therapeutic agents and treatment approaches.

  • Advanced biologics testing
  • Long-term disease management
  • Pediatric treatment options

Innovative therapies being evaluated for both induction and maintenance of remission.

03 Cardiovascular Health

Studies targeting cardiovascular disease prevention and treatment, including research on stroke prevention in atrial fibrillation and atherosclerosis management.

  • Heart failure treatments
  • Stroke prevention strategies
  • Hypertension management

Focus on both preventive measures and therapeutic interventions for various cardiac conditions.

04 Renal Studies

Investigation of treatments for chronic kidney disease, including both diabetic and non-diabetic conditions. Research evaluates novel therapeutic combinations and standalone treatments.

  • Kidney disease progression
  • Combination therapy approaches
  • Albumin reduction strategies

Emphasis on delaying disease progression and improving outcomes in kidney disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.